Insight into 144 patients with ocular vascular events during VEGF antagonist injections

References

• LiuMHJinHFlotenHSRenZYimAPHeGWVascular endothelial growth factor-mediated, endothelium-dependent relaxation in human internal mammary arteryAnn Thorac Surg200273381982411899958
   PubMed Web of Science ®Google Scholar
• ArevaloJFFromow-GuerraJQuiroz-MercadoHPrimary intravitreal bevacizumab (avastin) for diabetic macular edema. Results from the Pan-American Collaborative Study Group at 6-month follow-upOphthalmology2007114474375017398322
   PubMed Web of Science ®Google Scholar
• SolimanWVintenMSanderBOptical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedemaActa Ophthalmol200886436537118028237
   PubMed Web of Science ®Google Scholar
• MichaelidesMFraser-BellSHamiltonRMacular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): Report 1Retina201030578178620464787
   PubMed Web of Science ®Google Scholar
• KookDWolfAKreutzerTLong-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edemaRetina20082881053106018779710
   PubMed Web of Science ®Google Scholar
• Bonini-FilhoMCostaRACalucciDJorgeRMeloLAJrScottIUIntravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot studyAm J Ophthalmol200914761022103019327746
   PubMed Web of Science ®Google Scholar
• WuLMartínez-CastellanosMAQuiroz-MercadoHTwelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)Graefe’s Archive Clin Exp Ophthalmol200824618187
   PubMed Web of Science ®Google Scholar
• IkunoYSogaKWakabayashiTGomiFAngiographic changes after bevacizumab. [Letter.]Ophthalmology200911611226319883861
   PubMed Web of Science ®Google Scholar
• NeubauerASKookDHaritoglouDBevacizumab and retinal ischemia. [Letter.]Ophthalmology200711411209617980746
   PubMed Web of Science ®Google Scholar
• von HannoTKingeBFossenKRetinal artery occlusion following intravitreal anti-VEGF therapyActa Ophthalmol201088226326619416108
   PubMed Web of Science ®Google Scholar
• HuangZLLinKHLeeYCSheuMMTsaiRKAcute vision loss after intravitreal injection of bevacizumab (avastin) associated with ocular ischemic syndromeOphthalmologica20092242868919707032
   PubMed Web of Science ®Google Scholar
• ArtunayOYuzbasiogluERasierRSengulABahceciogluHAcute retinal arterial occlusion after intravenous administration of bevacizumabBMJ Case Rep200911478
   Google Scholar
• GanssaugeMWilhelmHBartz-SchmidtKUAisenbreySNon-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angioid streaks in pseudoxanthoma elasticumGraefes Arch Clin Exp Ophthalmol2009247121707171019916212
   PubMed Web of Science ®Google Scholar
• HosseiniHRazeghinejadMRAnterior ischemic optic neuropathy after intravitreal injection of bevacizumabJ Neuroophthalmol200929216016119491650
   PubMed Web of Science ®Google Scholar
• KofoedPKChristine MunchICLarsenMProfound retinal ischaemia after ranibizumab administration in an eye with ocular ischaemic syndromeActa Ophthalmologica201088780881019832734
   PubMed Web of Science ®Google Scholar
• FurinoCBosciaFCardasciaNAlessioGSborgiaCHemorrhagic macular infarction after intravitreal bevacizumab for central retinal vein occlusionOphthalmic Surg Lasers Imaging201091220337314
   PubMedGoogle Scholar
• ChenEHsuJParkCHAcute visual acuity loss following intravitreal bevacizumab for diabetic macular edemaOphthalmic Surg Lasers Imaging2009401687019205502
   PubMedGoogle Scholar
• MansourAMBynoeLAWelchJCRetinal vascular events after intravitreal bevacizumabActa Ophthalmol201088773073520039854
   PubMed Web of Science ®Google Scholar
• HuangJYOzakiHHayashiHUchioEAnterior ischemic optic neuropathy following intravitreal bevacizumabJpn J Ophthalmol201054325225420577866
   PubMed Web of Science ®Google Scholar
• BodlaAARaoPNon-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: is there an association?Indian J Ophthalmol201058434935020534939
   PubMed Web of Science ®Google Scholar
• KimNRChinHSProgression of impending central retinal vein occlusion to the ischemic variant following intravitreal bevacizumabKorean J Ophthalmol201024317918120532147
   PubMedGoogle Scholar
• YokoyamaKChochiTKimotoKShinodaKNakatsukaKRetinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucomaActa Ophthalmologica200886892792818494739
   PubMed Web of Science ®Google Scholar
• KimKSChangHRSongSIschaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusionActa Ophthalmol200886892592718494740
   PubMed Web of Science ®Google Scholar
• ShimaCSakaguchiHGomiFComplications in patients after intravitreal injection of bevacizumabActa Ophthalmol200886437237618028234
   PubMed Web of Science ®Google Scholar
• ShimuraMYasudaKMacular ischaemia after intravitreal bevacizumab injection in patients with central retinal vein occlusion and a history of diabetes and vascular diseaseBr J Ophthalmol201094338138320215378
   PubMed Web of Science ®Google Scholar
• Sabet-PeymanEJHeussenFMThorneJECasparisHPatelSJDoDVProgression of macular ischemia following intravitreal bevacizumabOphthalmic Surg Lasers Imaging200940331631819485300
   PubMedGoogle Scholar
• FungAERosenfeldPJReichelEThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBr J Ophthalmol200690111344134916854824
   PubMed Web of Science ®Google Scholar
• WuWCYehPTChenSNYangCMLaiCCKuoHKEffects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in TaiwanOphthalmology2011118117618320673589
   PubMed Web of Science ®Google Scholar
• GoelNKumarVGhoshBIschemic maculopathy following intravitreal bevacizumab for refractory diabetic macular edemaInt Ophthalmol2011311394220852916
   PubMedGoogle Scholar
• MassinPBandelloFGarwegJSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes Care201033112399240520980427
   PubMed Web of Science ®Google Scholar
• YuXRWangXZClinical effect for intravitreal injection of avastin for 400 cases fundus diseaseInternational Journal of Ophthalmology20101019131915
   Google Scholar
• ShinYWLeeYJLeeBRChoHYEffects of an intravitreal bevacizumab injection combined with panretinal photocoagulation on high-risk proliferative diabetic retinopathyKorean J Ophthalmol200923426627220046686
   PubMedGoogle Scholar
• Battaglia ParodiMIaconoPCascavillaMLSequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edemaEur J Ophthalmol20102061076107820954148
   PubMed Web of Science ®Google Scholar
• GilbarPSorourNRetinal vein thrombosis in a patient with metastatic colon cancer receiving XELOX chemotherapy combined with bevacizumab pre-hepatic resectionJ Oncol Pharm Pract3222011 [Epub ahead of print.]
   Google Scholar
• LeeSJKohHJEnlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (avastin) with pars plana vitrectomyJ Ocul Pharmacol Ther200925217317419284326
   PubMed Web of Science ®Google Scholar
• LeeCSKohHJMultiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomyActa Ophthalmologica200886781281318093262
   PubMed Web of Science ®Google Scholar
• TeruiTKondoMSugitaTChanges in area of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusionRetina20113161068107421451440
   PubMed Web of Science ®Google Scholar
• KimakuraMOishiAMandaiMKurimotoYBilateral nonarteritic anterior ischemic optic neuropathy following intravitreal injection of pegaptanibClin Exp Ophthalmol2011226
   Google Scholar
• CATT Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for neovascular age-related macular degenerationNew Eng J Med2011364201897190821526923
   PubMed Web of Science ®Google Scholar
• lmanMJBresslerNMQinHExpanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology2011118460961421459214
   PubMed Web of Science ®Google Scholar
• WongLJDesaiRUJainASurveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular diseaseRetina20082881151115818685542
   PubMed Web of Science ®Google Scholar
• ShermanJHAregawiDGLaiAOptic neuropathy in patients with glioblastoma receiving bevacizumabNeurology200973221924192619949039
   PubMed Web of Science ®Google Scholar
• TolentinoMSystemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular diseaseSurv Ophthalmol20115629511321335144
   PubMed Web of Science ®Google Scholar
• Van der ReisMLa HeijECDe Jong-HesseYRingensPJHendrikseFSchoutenAGA systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injectionsRetina20113181449146921817960
   PubMed Web of Science ®Google Scholar
• LarsenMColmornLBBønnelyckeMRetinal artery and vein diameters during pregnancy in diabetic womenInvest Ophthalmol Vis Sci200546270971315671303
   PubMed Web of Science ®Google Scholar
• KofoedPKSanderBZubieta-CallejaGKesselLLarsenMRetinal vessel diameters in relation to hematocrit variation during acclimatization of highlanders to sea level altitudeInvest Ophthalmol Vis Sci20095083960396319339736
   PubMed Web of Science ®Google Scholar
• SchutzFAJeYAzziGRNguyenPLChoueiriTKBevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomesAnn Oncol20102261404141221115602
   PubMed Web of Science ®Google Scholar
• MouradJJdes GuetzGDebbabiHLevyBIBlood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculationAnn Oncol200819592793418056916
   PubMed Web of Science ®Google Scholar
• CostaRAJorgeRCalucciDMeloLAJrCardilloJAScottIUIntravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO studyRetina200727214114917290194
   PubMed Web of Science ®Google Scholar
• ChungEJRohMIKwonOWKohYJEffects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edemaRetina200828795796318698297
   PubMed Web of Science ®Google Scholar
• PapadopoulouDNMendrinosEMangiorisGDonatiGPournarasCJIntravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degenerationOphthalmology200911691755176119560206
   PubMed Web of Science ®Google Scholar
• MendrinosEMangiorisGPapadopoulouDDonatiGPournarasCOne year results of the effect of intravitreal ranibizumab on the retinal arteriolar diameter in patients with neovascular age-related macular degenerationInvest Ophthalmol Vis Sci12132011 [Epub ahead of print.]
   Google Scholar
• SacuSPempBWeigertGResponse of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusionInv Ophthalmol Vis Sci201152630463050
   PubMed Web of Science ®Google Scholar
• RasierRArtunayOYuzbasiogluESengulABahceciogluHThe effect of intravitreal bevacizumab (avastin) administration on systemic hypertensionEye20092381714171819079149
   PubMed Web of Science ®Google Scholar
• MatsuyamaKOgataNMatsuokaMWadaMTakahashiKNishimuraTPlasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumabBr J Ophthalmol20109491215121820538658
   PubMed Web of Science ®Google Scholar
• LeeKYangHLimHLewHMA prospective study of blood pressure and intraocular pressure changes in hypertensive and non-hypertensive patients after intravitreal bevacizumab injectionRetina200929101409141719816242
   PubMed Web of Science ®Google Scholar
• Feldman-BillardSChibaniAHéronEIntravitreal triamcinolone and blood glucose (letter)Ophthalmology2008115591718452767
   PubMed Web of Science ®Google Scholar
• KhaliliMRMehdizadehMMehryarMHerpetic epithelial keratitis after intravitreal injection of bevacizumab (avastin)Cornea200928336036119387245
   PubMed Web of Science ®Google Scholar
• AdelmanRAZhengQMayerHRPersistent ocular hypertension following intravitreal bevacizumab and ranibizumab injectionsJ Ocul Pharmacol Ther201026110511020187807
   PubMed Web of Science ®Google Scholar
• GismondiMSalatiCSalvetatMLZeppieriMBrusiniPShort-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressureJ Glaucoma200918965866120010243
   PubMed Web of Science ®Google Scholar
• ShareiVHöhnFKöhlerTHattenbachLOMirshahiACourse of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis)Eur J Ophthalmol201020117417919927267
   PubMed Web of Science ®Google Scholar
• SemounOBlumen-OhanaEde PreobrajenskyNNordmannJPAcute angle-closure glaucoma complicating an intravitreal injection of bevacizumab [Glaucome aigu par fermeture de l’angle compliquant une injection intravitréenne de bevacizumab]J Fr Ophtalmol200932158e1e4 [French.]
   Web of Science ®Google Scholar
• KingeBStordahlPBForsaaVEfficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC studyAm J Ophthalmol2010150331031420591399
   PubMed Web of Science ®Google Scholar
• BrownDMMichelsMKaiserPKRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR studyOphthalmology20091161576519118696
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationNew Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• PetersSHeiduschkaPJulienSUltrastructural findings in the primate eye after intravitreal injection of bevacizumabAm J Ophthalmol20071436995100217449002
   PubMed Web of Science ®Google Scholar
• SchraermeyerUSchultheissSHofmeisterSJulienSBevacizumab immune complexes activate platelets and cause thrombosis in choroidal vessels of primate eyesInvest Ophthalmol Vis Sci2011suppl ARVO Paper No. 5271
   Google Scholar
• MeyerTRobles-CarrilloLRobsonTBevacizumab immune complexes activate platelets and induce thrombosis in FCGR2 A transgenic miceJ Thromb Haemost20097117118118983497
   PubMed Web of Science ®Google Scholar
• AmeriHChaderGJKimJGSaddaSRRaoNAHumayunMSThe effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbitsInvest Ophthalmol Vis Sci200748125708571518055823
   PubMed Web of Science ®Google Scholar
• BonninPPournarasJ-ACLazrakZUltrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin®) in neovascular age-related macular degenerationActa Ophthalmol201088664164519563370
   PubMed Web of Science ®Google Scholar